Mark Meuth
- Oncology top 0.5%
- Cancer-related Molecular Pathways 9
- Molecular Biology top 0.5%
- DNA Repair Mechanisms 26
- Biochemical and Molecular Research 18
- CRISPR and Genetic Engineering 16
- Cancer Research top 1%
- Carcinogens and Genotoxicity Assessment 8
- Genetics top 2%
-
- Genetic factors in colorectal cancer 10
-
- Bladder and Urothelial Cancer Treatments 8
-
- HIV/AIDS drug development and treatment 6
- Co-authors
- Howard GreenThomas HelledayNiklas SchultzHelen E. BryantSuzanne KyleHuw D. ThomasNicola J. CurtinElena López‐Knowles
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Mark Meuth
68 papers receiving 8.7k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Oncology 3.8k
- Molecular Biology 6.7k
- Cancer Research 1.5k
- Genetics 1.1k
- Pathology and Forensic Medicine 665
Countries citing papers authored by Mark Meuth
This map shows the geographic impact of Mark Meuth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Meuth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Meuth more than expected).
Fields of papers citing papers by Mark Meuth
This network shows the impact of papers produced by Mark Meuth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Meuth. The network helps show where Mark Meuth may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Meuth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 26 | |
| 2 | 2015 | 19 | |
| 3 | 2014 | 2 | |
| 4 | 2011 | 32 | |
| 5 | 2009 | 272 | |
| 6 | 2009 | 109 | |
| 7 | 2008 | 44 | |
| 8 | 2007 | 143 | |
| 9 | 2007 | 12 | |
| 10 | FGFR3 mutations have different effects on disease course in tumors from the bladder, ureter, and renal pelvis | 2006 | 0 |
| 11 | Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerasebreakdown → | 2005 | 3780 |
| 12 | 2005 | 155 | |
| 13 | 2004 | 76 | |
| 14 | 2003 | 0 | |
| 15 | 2003 | 111 | |
| 16 | 1994 | 5 | |
| 17 | 1991 | 11 | |
| 18 | 1990 | 26 | |
| 19 | 1989 | 3 | |
| 20 | 1989 | 208 |
About Mark Meuth
Mark Meuth is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 71 papers that have together received 8.9k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (26 papers), Biochemical and Molecular Research (18 papers), CRISPR and Genetic Engineering (16 papers), Genetic factors in colorectal cancer (10 papers), Cancer-related Molecular Pathways (9 papers), Carcinogens and Genotoxicity Assessment (8 papers), Bladder and Urothelial Cancer Treatments (8 papers) and HIV/AIDS drug development and treatment (6 papers). The work is most often cited by research in Oncology (3.8k citations), Molecular Biology (6.7k citations) and Cancer Research (1.5k citations). Mark Meuth has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Howard Green, Thomas Helleday, Niklas Schultz, Helen E. Bryant, Suzanne Kyle, Huw D. Thomas, Nicola J. Curtin, Elena López‐Knowles, Freddie C. Hamdy and James W.F. Catto. Their work appears in journals such as Molecular and Cellular Biology, Nucleic Acids Research, Cell, Clinical Cancer Research and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.